Click here to go to the previous page
Real, Transparent Dialogue from Three Sponsors: Destination eTMF - Are We There Yet?
Program Code:
272
Date:
Tuesday, June 25, 2013
Time:
4:00 PM to 5:30 PM
EST
CHAIR
:
Nancie E. Celini,
DrPH,MPH (SCHNON), Chief Learning Consultant,
CAB Inc., United States
Ms. Celini is a health care technology and informatics professional with over 30 years in the life science industry. She specializes in training and implementation of enterprise systems in life science.
|
PANELIST
(S):
Betsy Fallen, RN (SPKNON), Lead, Global Essential Document and Supply Chain Management, Merck & Co., Inc., United States
Graeme Currie,
PhD (SPKNON), Head, Clinical Project Management Office,
Regeneron Pharmaceuticals, United States
Graeme Currie, PhD, is Executive Director at Regeneron. Dr. Currie is responsible for clinical operations activity Phase 1 to 4 for CNS/Respiratory. Dr. Currie has held positions with Wellcome Research Laboratories, Quintiles and Ipsen International . He holds a Ph.D. from Aston University.
|
Ivan P. Walrath, MS (SPKNON), Process Owner, Trial Master File, Pfizer Inc, United States
Description
This unique interview format includes three industry sponsors in various stages of eTMF transition. This forum is designed to help other sponsors, currently in the process of planning their eTMF strategy and programs, share in these real-world experiences. This open discussion will explore the realities encountered by these sponsor organizations and how they mitigated or plan to mitigate the unexpected barriers.